Mouse CRELD2 Antibody
R&D Systems, part of Bio-Techne | Catalog # AF3686
Scientific images may be resized, cropped, or adjusted for brightness or contrast for presentation purposes. These updates are limited to presentation and do not affect the underlying scientific interpretation of the data. Where available, additional source data may be provided upon request.
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Mouse
Cited:
Mouse
Applications
Validated:
Western Blot
Cited:
Immunohistochemistry, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant mouse CRELD2
Ser23-Leu350
Accession # Q9CYA0
Ser23-Leu350
Accession # Q9CYA0
Specificity
Detects mouse CRELD2 in direct ELISAs and Western blots. In direct ELISAs and Western blots, approximately 10% cross-reactivity with recombinant human CRELD2 is observed and less than 1% cross-reactivity with recombinant mouse CRELD1 is observed.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Scientific Data Images for Mouse CRELD2 Antibody
Detection of CRELD2 by Western Blot
Lack of CRELD2 effects in murine embryonic fibroblasts.(a) EdU incorporation in mouse embryonic fibroblasts (MEFs) cultured for 24 hours in the absence or presence of transforming growth factor beta 1 (TGF beta1, 2 ng/mL) or CRELD2 (100 ng/mL). 3–6 experiments. (b) Recovery 16 hours after scratch injury of MEF monolayers in the absence or presence of TGF beta1 or CRELD2. 4 experiments. (c) Smooth muscle actin alpha 2 (Acta2) and (d) collagen type I alpha1 (Col1a1) mRNA expression (RT-qPCR, normalized to glyceraldehyde-3-phosphate dehydrogenase [Gapdh]) in MEFs cultured for 24 hours in the absence or presence of TGF beta1 or CRELD2. 6 experiments. (a–d) *P < 0.05, **P < 0.01, ***P < 0.001 (1-way ANOVA with Tukey test). Individual data points, mean values, and SEMs are shown. (e) Exemplary immunoblots (out of 3) showing phosphorylated (P)-SMAD2 (S465/S467), P-SMAD3 (S423/S425), and SMAD2 and SMAD3 expression in MEFs stimulated with TGF beta1 in the absence or presence of CRELD2 (added 30 min prior to TGF beta1).Source data Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/39196188), licensed under a CC-BY license. Not internally tested by R&D Systems.Applications for Mouse CRELD2 Antibody
Application
Recommended Usage
Western Blot
0.1 µg/mL
Sample: Recombinant Mouse CRELD2
Sample: Recombinant Mouse CRELD2
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Shipping
Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: CRELD2
Long Name
Cysteine-rich Protein With EGF-like Domains 2
Alternate Names
cysteine-rich with EGF-like domain protein 2, cysteine-rich with EGF-like domains 2, DKFZp667O055, MGC11256
Gene Symbol
CRELD2
UniProt
Additional CRELD2 Products
Product Documents for Mouse CRELD2 Antibody
Product Specific Notices for Mouse CRELD2 Antibody
For research use only
Loading...
Loading...
Loading...
Loading...
Loading...